Post by Industry Magnates

Unveiling the Latest Edition of STALWARTZ Featuring Mukund Shastry We’re thrilled to present our newest issue, packed with captivating stories, deep insights, and inspirational perspectives. In this edition, we are proud to feature Mukund Shastry, Senior Board Advisor, CXO Consultant, Certified Independent Director at Pharma & Healthcare , as part of the STALWARTZ Magazine series – a World Development Corporation Initiative. Mukund Shastry is an accomplished professional with over three decades of experience in the pharmaceutical industry, boasting a diverse background spanning sales, marketing, strategy and leadership roles. He is a Senior Board Advisor and Leadership Mentor today, helping pharma and biotech organisations commercialize globally, as well as mid and senior career professionals mentorship, cross-culturally and cross-functionally. Mukund's illustrious career spans over three decades, marked by significant contributions to various pharmaceutical organisations across the globe. His journey began as a Management Trainee at Nicholas Piramal, followed by roles as a Product Manager at Alembic Limited and a Group Product Manager at Sun Pharma. Notably, his tenure at Ranbaxy thereafter saw him assume diverse roles, including Marketing Manager, Senior Manager (Strategy) and pivotal cross -functional leadership roles in Peru, Ecuador, Bolivia, Thailand and Malaysia, including Country Manager roles (Managing Director of the entity at Thailand). In This Exclusive Feature, You’ll Discover: Strategic Disruption and Competitive Advantage in Pharmaceuticals: Lessons for the Next Decade Leading Across Borders: Defining the Cultural Bridge Strategic Reinvention - The New Sustainable "Global CompetitiveAdvantage" How boards can architect renewal before market forces compel change Join us in exploring these unique perspectives and experiences. Don’t miss out on this enriching read! 👉 Visit: https://lnkd.in/g7eFePCP #DirectorsInstitute #BoardOfDirectors #GlobalBoardMember #CareerGrowth #Leadership #Governance #SustainableInvesting #ESG #IndependentDirectors #BoardOversight #GovernanceBestPractices #SEBI #Sustainability #NonExecutiveDirector #IndependentDirectorRoles